Micron Technology, Inc. Reports Results for the Second Quarter of Fiscal 2024
20 mars 2024 16h06 HE
|
Micron Technology, Inc.
BOISE, Idaho, March 20, 2024 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced results for its second quarter of fiscal 2024, which ended February 29, 2024. Fiscal Q2 2024...
Micron Technology to Report Fiscal Second Quarter Results on March 20, 2024
20 févr. 2024 16h01 HE
|
Micron Technology, Inc.
BOISE, Idaho, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), announced today that it will hold its fiscal second quarter earnings conference call on Wednesday, March 20,...
Micron Technology to Report Fiscal First Quarter Results on December 20, 2023
16 nov. 2023 16h01 HE
|
Micron Technology, Inc.
BOISE, Idaho, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), announced today that it will hold its fiscal first quarter earnings conference call on Wednesday, Dec. 20, 2023,...
Esperion Reports Third Quarter 2023 Financial Results
07 nov. 2023 06h00 HE
|
Esperion Therapeutics, Inc.
– Q3 U.S. Net Product Revenue Grew 45% Y/Y to $20.3 Million; Q3 Total Revenue Grew 79% Y/Y to $34.0 Million – – Q3 Retail Prescription Equivalents Grew 33% Y/Y and 8% Q/Q, Demonstrating Sustained...
Micron Technology, Inc. Reports Results for the Fourth Quarter and Full Year of Fiscal 2023
27 sept. 2023 16h01 HE
|
Micron Technology, Inc.
BOISE, Idaho, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced results for its fourth quarter and full year of fiscal 2023, which ended August 31, 2023. ...
Micron Technology to Report Fiscal Fourth Quarter Results on September 27, 2023
29 août 2023 16h01 HE
|
Micron Technology, Inc.
BOISE, Idaho, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), announced today that it will hold its fiscal fourth quarter earnings conference call on Wednesday, September 27,...
Esperion Reports Second Quarter 2023 Financial Results
01 août 2023 06h00 HE
|
Esperion Therapeutics, Inc.
– Q2 U.S. Net Product Revenue Grew 49% Y/Y to $20.3 Million – – Q2 Retail Prescription Equivalents Grew 26% Y/Y; Q2 New to Brand Prescriptions Grew 28% Q/Q – – Submitted Applications for Expanded...
Micron Technology, Inc. Reports Results for the Third Quarter of Fiscal 2023
28 juin 2023 16h04 HE
|
Micron Technology, Inc.
BOISE, Idaho, June 28, 2023 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced results for its third quarter of fiscal 2023, which ended June 1, 2023. Fiscal Q3 2023...
Micron Technology to Report Fiscal Third Quarter Results on June 28, 2023
01 juin 2023 16h01 HE
|
Micron Technology, Inc.
BOISE, Idaho, June 01, 2023 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), announced today that it will hold its fiscal third quarter earnings conference call on Wednesday, June 28, 2023,...
FibroGen to Report First Quarter 2023 Financial Results
24 avr. 2023 07h00 HE
|
FibroGen, Inc.
SAN FRANCISCO, April 24, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its first quarter 2023 financial results on Monday, May 8 after the market close. FibroGen will also...